Insider Selling: HealthEquity (NASDAQ:HQY) EVP Sells 2,470 Shares

HealthEquity, Inc. (NASDAQ:HQY) EVP Michael Henry Fiore sold 2,470 shares of the firm’s stock in a transaction that occurred on Thursday, July 2nd. The shares were sold at an average price of $95.00, for a total transaction of $234,650.00. Following the completion of the sale, the executive vice president directly owned 56,643 shares in the company, valued at $5,381,085. This represents a 4.18% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Michael Henry Fiore also recently made the following trade(s):

• On Friday, May 29th, Michael Henry Fiore sold 3,142 shares of HealthEquity stock. The stock was sold at an average price of $95.00, for a total transaction of $298,490.00.

HealthEquity Price Performance

Shares of HealthEquity stock traded up $0.41 on Tuesday, hitting $96.98. 664,544 shares of the company traded hands, compared to its average volume of 1,014,519. HealthEquity, Inc. has a 12-month low of $72.76 and a 12-month high of $105.96. The company has a current ratio of 3.44, a quick ratio of 3.44 and a debt-to-equity ratio of 0.46. The company has a market cap of $8.11 billion, a P/E ratio of 36.32, a P/E/G ratio of 1.60 and a beta of 0.21. The firm’s 50-day simple moving average is $86.41 and its 200 day simple moving average is $84.60.

HealthEquity (NASDAQ:HQY) last announced its earnings results on Thursday, May 28th. The company reported $1.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.11 by $0.13. HealthEquity had a net margin of 17.25% and a return on equity of 14.75%. The company had revenue of $354.64 million during the quarter, compared to analyst estimates of $352.02 million. The firm’s revenue for the quarter was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. Analysts expect that HealthEquity, Inc. will post 3.92 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of brokerages recently weighed in on HQY. BMO Capital Markets raised HealthEquity from a “market perform” rating to an “outperform” rating and raised their price objective for the company from $85.00 to $105.00 in a report on Thursday, April 9th. Weiss Ratings raised shares of HealthEquity from a “hold (c)” rating to a “hold (c+)” rating in a research note on Friday, June 5th. Barrington Research restated an “outperform” rating and issued a $110.00 price objective on shares of HealthEquity in a report on Friday, May 22nd. Citizens Jmp increased their target price on shares of HealthEquity from $110.00 to $111.00 and gave the company a “market outperform” rating in a report on Monday, June 1st. Finally, Wall Street Zen cut shares of HealthEquity from a “buy” rating to a “hold” rating in a research report on Saturday. One investment analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $110.57.

Hedge Funds Weigh In On HealthEquity

Several hedge funds and other institutional investors have recently modified their holdings of HQY. William Blair Investment Management LLC bought a new stake in HealthEquity during the 4th quarter valued at approximately $169,956,000. Norges Bank purchased a new position in shares of HealthEquity in the 4th quarter valued at approximately $66,927,000. AQR Capital Management LLC lifted its stake in shares of HealthEquity by 148.5% in the 2nd quarter. AQR Capital Management LLC now owns 1,107,448 shares of the company’s stock valued at $116,016,000 after purchasing an additional 661,795 shares during the period. Wasatch Advisors LP boosted its position in shares of HealthEquity by 9.3% during the first quarter. Wasatch Advisors LP now owns 7,202,934 shares of the company’s stock valued at $601,949,000 after purchasing an additional 613,288 shares in the last quarter. Finally, Millennium Management LLC boosted its position in shares of HealthEquity by 151.5% during the fourth quarter. Millennium Management LLC now owns 951,563 shares of the company’s stock valued at $87,173,000 after purchasing an additional 573,283 shares in the last quarter. 99.55% of the stock is owned by institutional investors.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.